The spinal surgery/spinal care market has been marked in recent years
by a few trends that run counter to how many investors historically see
the med-tech market. First, size hasn't proven to be such an
insurmountable competitive advantage, as up-and-comers like NuVasive (NASDAQ:NUVA), LDR Holding (NASDAQ:LDRH), and Globus (NYSE:GMED) have gained share at the expense of larger rivals like Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT).
Second, and apologies for the obvious pun, it seems to be one of the
few areas of medicine where insurers have found some backbone and pushed
back on pricing.
The subject of this article, LDR Holding,
strikes me as an appealing growth story in med-tech by virtue of its
commitment to doing things differently in the spinal space. Not only
does the company have a strong product in the fast-growing cervical disc
replacement market, but the company is also advancing technology in the
lumbar area that features less hardware and less collateral damage to
the patient. LDR Holding still has a difficult climb on its way to the
top, including not only competition with the likes of JNJ and Medtronic,
but also surgeon inertia, and the valuation is not obviously cheap, but
the balance between growth and valuation is at least promising enough
to look closer.
Click here for the full article:
LDR Holding Corp. Seems To Be In The Right Place At The Right Time
No comments:
Post a Comment